Brief: PCI Biotech Q2 Operating Loss At NOK 7.2 Million
Aug 30 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* Q2 OPERATING LOSS NOK 7.2 MILLION VERSUS LOSS NOK 7.2 MILLION YEAR AGO
* NET LOSS FOR THE Q2 WAS NOK 7.1 MILLION (NOK 7.0 MILLION)
* THE GROUP DID NOT RECORD REVENUES FOR Q2 AND 1H 2018
Source text for Eikon: ID:nGNEybLX1
Further company coverage: PCIB.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process